Endothelial tight junction (TJ)

Endothelial tight junctions are specialized intercellular adhesion complexes that regulate the paracellular permeability of the vascular endothelium, acting as a critical gatekeeper for the movement of fluids, ions, and macromolecules (PMID: 28811321). They are most highly developed in the blood-brain barrier (BBB), where they form a high-resistance seal that protects the central nervous system from toxins and pathogens while maintaining ionic homeostasis (PMID: 19217254). The molecular architecture of these junctions consists of transmembrane proteins, such as claudins (primarily Claudin-5), occludin, and junctional adhesion molecules (JAMs), which are linked to the actin cytoskeleton via cytoplasmic scaffolding proteins like zonula occludens (ZO-1, ZO-2, and ZO-3) (PMID: 21248271). Dysregulation of endothelial tight junctions is a hallmark of various pathologies, including ischemic stroke, where barrier breakdown leads to life-threatening cerebral edema, and cancer, where it facilitates tumor cell extravasation and metastasis (PMID: 25653336). Therapeutically, these junctions are targeted either to transiently increase permeability for the delivery of CNS-active drugs—using osmotic agents like mannitol or biochemical modulators like bradykinin analogs—or to stabilize the barrier in inflammatory and neurodegenerative conditions (PMID: 30355571).

Other names

Zonula occludensOccluding junctionEndothelial barrierIntercellular tight junction

Modulation of paracellular permeability through the reversible disruption of transmembrane protein-protein interactions (e.g., claudin-5, occludin) or the induction of endothelial cell shrinkage via osmotic gradients to widen junctional spaces (PMID: 25653336, PMID: 30355571).